TEVA stock fundamentals - financials as reported

Financials As Reported

  • accession Number 0001193125-23-140697
  • accounts Receivable Net Current 3,435,000,000
  • accumulated Other Comprehensive Income Loss Net Of Tax --2,701,000,000
  • amendment Flag false
  • assets 43,456,000,000
  • assets Current 11,501,000,000
  • cash And Cash Equivalents At Carrying Value 2,143,000,000
  • cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents 2,176,000,000
  • cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect --658,000,000
  • cik 818,686
  • city Area Code +972 (3)
  • common Stock Par Or Stated Value Per Share 0.1
  • common Stock Shares Authorized 2,495,000,000
  • common Stock Shares Issued 1,226,000,000
  • comprehensive Income Net Of Tax --69,000,000
  • cost Of Goods And Services Sold 2,079,000,000
  • current Fiscal Year End Date --12-31
  • date Filed 2023-05-10
  • document Fiscal Period Focus Q1
  • document Fiscal Year Focus 2,023
  • document Period End Date 2023-03-31
  • document Transition Report false
  • document Type 10-Q
  • earnings Per Share Basic -0.18
  • earnings Per Share Diluted -0.18
  • entity Address Address Line 1 124 Dvora HaNevi’a St.
  • entity Address City Or Town Tel Aviv
  • entity Address Postal Zip Code 6,944,020
  • entity Central Index Key 818,686
  • entity Current Reporting Status Yes
  • entity Emerging Growth Company false
  • entity File Number 001-16174
  • entity Filer Category Large Accelerated Filer
  • entity Incorporation State Country Code L3
  • entity Interactive Data Current Yes
  • entity Name TEVA PHARMACEUTICAL INDUSTRIES LTD
  • entity Registrant Name TEVA PHARMACEUTICAL INDUSTRIES LIMITED
  • entity Shell Company false
  • entity Small Business false
  • entity Tax Identification Number 00-0000000
  • gross Profit 1,582,000,000
  • income Tax Expense Benefit --19,000,000
  • inventory Net 4,118,000,000
  • irs Number 0
  • liabilities 34,844,000,000
  • liabilities And Stockholders Equity 43,456,000,000
  • liabilities Current 10,411,000,000
  • liabilities Noncurrent 24,433,000,000
  • local Phone Number 914-8213
  • long Term Debt Current 1,000,000,000
  • net Cash Provided By Used In Financing Activities --706,000,000
  • net Cash Provided By Used In Investing Activities 181,000,000
  • net Cash Provided By Used In Operating Activities --145,000,000
  • net Income Loss --205,000,000
  • nonoperating Income Expense --260,000,000
  • operating Income Loss 2,000,000
  • operating Lease Liability Noncurrent 345,000,000
  • operating Lease Right Of Use Asset 420,000,000
  • other Assets Current 542,000,000
  • other Assets Noncurrent 450,000,000
  • other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax 120,000,000
  • other Liabilities Current 1,000,000,000
  • other Liabilities Noncurrent 3,869,000,000
  • payments For Proceeds From Other Investing Activities 1,000,000
  • payments To Acquire Businesses Net Of Cash Acquired 0
  • payments To Acquire Property Plant And Equipment 139,000,000
  • period End 1,680,220,800,000
  • period Start 1,672,531,200,000
  • proceeds From Payments For Other Financing Activities --5,000,000
  • property Plant And Equipment Net 5,751,000,000
  • repayments Of Long Term Debt 3,152,000,000
  • report Link https://www.sec.gov/Archives/edgar/data/818686/000119312523140697/d464631d10q_htm.xml
  • retained Earnings Accumulated Deficit --13,086,000,000
  • revenue From Contract With Customer Excluding Assessed Tax 3,661,000,000
  • share Based Compensation 32,000,000
  • stockholders Equity 7,860,000,000
  • trading Symbol TEVA
  • update 1970-01-01
  • weighted Average Number Diluted Shares Outstanding Adjustment 1,115,000,000
  • weighted Average Number Of Diluted Shares Outstanding 1,115,000,000
  • weighted Average Number Of Shares Outstanding Basic 1,115,000,000
  • id REPORTED_FINANCIALS
  • key TEVA
  • subkey 10-Q
  • date 2023-05-10
  • updated 2023-05-11